title: Anti-alcohol medication and pregnancy: weighing the risks.
abstract: When there is a major risk of alcohol withdrawal symptoms in a pregnant woman, a 7-day course of benzodiazepine therapy has a positive harm-benefit balance. Medications designed to help maintain abstinence are not sufficiently effective to warrant initiating treatment during pregnancy.
mesh_terms: D001569:Benzodiazepines / Q000009:adverse effects; D000431:Ethanol / Q000009:adverse effects*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D001569:Benzodiazepines; D000431:Ethanol